Table 1 Patients’ characteristics at admission

Female n (%)

4 (28.57)

5 (35.72)

ns

9 (32.1)

Male n (%)

10 (71.43)

9 (64.28)

ns

19 (67.9)

Age median (Q1-Q3)

59 (46-69)

74 (58-79)

ns

62 (54-76)

Non-survivor in 28 days n (%)

1 (7)

4 (28.5)

ns

5 (17.9)

Charlson median (Q1-Q3)

2 (0-2.8)

2.5 (1.3-3.8)

ns

2 (0.75-3.25)

SAPSII on admission median (Q1-Q3)

34 (29-40)

56 (49-63)

<0.0001

45 (34-56)

Duration length in ICU median (Q1-Q3)

10 (5-11)

11 (6-30)

ns

10 (5-14)

SOFA H6

11 (9-13)

10 (9-13)

ns

10 (9-13)

Comorbidity n (%)

ns

 0

9 (64.3)

7 (50)

16 (57.1)

 1

4 (28.6)

5 (35.7)

9 (32.1)

 >2

1 (7.1)

2 (14.3)

3 (10.7)

Type of admission n (%)

ns

 Surgery

5 (35.7)

8 (57.1)

13 (46.4)

 Medical

9 (64.3)

6 (42.9)

15 (53.6)

Type of infection n (%)

ns

 Community acquired

6 (42.86)

9 (64.29)

15 (53.5)

 Hospital acquired

8 (57.14)

5 (35.71)

13 (46.4)

Suspected infection n (%)

 Clinically documented diagnosis

1 (7)

3 (21.4)

4 (16.6)

 Microbiologically documented diagnosis

13 (93)

11 (79)

24 (86)

  Bacilli Gram (−)

10 (77)

7 (64)

ns

17 (61)

  Cocci Gram (+)

5 (38)

7 (64)

ns

12 (43)

  Fungi

2 (15)

0

2 (7)

Cell count

 White blood cells (giga/L)

13.16 (7.52-16.93)

6.97 (3.23-15.68)

ns

11.07 (5.9-16.3)

 Lymphocytes

0.73 (0.32-1.22)

0.68 (0.4-1.33)

ns

0.72 (0.35-1.3)

 Polymorphonuclear cells

10.14 (6.6-14.31)

5.45 (2.5-12.61)

ns

9.56 (4.21-13.12)

 Monocytes

0.57 (0.49-1.66)

0.45 (0.19-0.66)

ns

0.55 (0.38-0.67)